LARP4B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.850800040477E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.88060000000578E-06 |
Normal-vs-Stage2 |
4.1379000000008E-05 |
Normal-vs-Stage3 |
3.37000427563794E-11 |
Normal-vs-Stage4 |
3.61849999963582E-07 |
Stage1-vs-Stage2 |
2.717000E-01 |
Stage1-vs-Stage3 |
5.801600E-04 |
Stage1-vs-Stage4 |
5.858000E-02 |
Stage2-vs-Stage3 |
1.814640E-01 |
Stage2-vs-Stage4 |
6.658200E-01 |
Stage3-vs-Stage4 |
3.448800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.82350040517565E-10 |
Normal-vs-AfricanAmerican |
1.371720E-02 |
Normal-vs-Asian |
7.187400E-01 |
Caucasian-vs-AfricanAmerican |
1.378050E-02 |
Caucasian-vs-Asian |
6.106300E-02 |
AfricanAmerican-vs-Asian |
3.965400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.360100141516E-10 |
Normal-vs-Female |
1.52434999999285E-05 |
Male-vs-Female |
1.868240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.502700E-03 |
Normal-vs-Age(41-60Yrs) |
1.3682999999709E-06 |
Normal-vs-Age(61-80Yrs) |
8.76269945493391E-10 |
Normal-vs-Age(81-100Yrs) |
8.21020000000283E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.553000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.634400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.114200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.819900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.844380E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.262600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.229400E-01 |
Normal-vs-Grade 2 |
1.78322999999647E-05 |
Normal-vs-Grade 3 |
4.04679956211851E-10 |
Normal-vs-Grade 4 |
2.9811000334945E-09 |
Grade 1-vs-Grade 2 |
5.530400E-02 |
Grade 1-vs-Grade 3 |
3.478900E-03 |
Grade 1-vs-Grade 4 |
7.998400E-04 |
Grade 2-vs-Grade 3 |
1.358180E-02 |
Grade 2-vs-Grade 4 |
6.422300E-03 |
Grade 3-vs-Grade 4 |
4.692000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.98540000054359E-07 |
Normal-vs-ccB subtype |
4.32629999602696E-08 |
ccA subtype-vs-ccB subtype |
1.800830E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.26679999823409E-08 |
Normal-vs-N1 |
2.586400E-01 |
N0-vs-N1 |
8.124100E-02 |
|
|